Roles of Calpain-calpastatin System (CCS) in Human T Cell Activation
Overview
Authors
Affiliations
The immune response is determined by the speed of the T cell reaction to antigens assured by a state of readiness for proliferation and cytokine secretion. Proliferation, apoptosis and motion of many cell types are controlled by cytoplasmic proteases - µ- and m-calpain - and their inhibitor calpastatin, together forming the "calpain-calpastatin system" (CCS), assumed to modify their targets only upon activation-dependent cytoplasmic Ca2+ increase. Contrastingly to this notion, using quantitative real time PCR and semiquantitative flow cytometry respectively, we show here that the CCS genes are constitutively expressed, and that both calpains are constitutively active in resting, circulating human CD4+ and CD8+ lymphocytes. Furthermore, we demonstrate that calpain inhibition in the resting T cells prevents them from proliferation in vitro and greatly reduces secretion of multiple cytokines. The mechanistic reason for these effects of calpain inhibition on T cell functions might be the demonstrated significant reduction of the expression of active (phosphorylated) upstream signalling molecules, including the phospholipase C gamma, p56Lck and NFκB, in the inhibitor-treated cells. Thus, we propose that the constitutive, self-regulatory calpain-calpastatin system activity in resting human T cells is a necessary, controlling element of their readiness for complex and effective response to antigenic challenge.
A Putative Role for TRPC6 in Immune-Mediated Kidney Injury.
t Hart D, van der Vlag J, Nijenhuis T Int J Mol Sci. 2023; 24(22).
PMID: 38003608 PMC: 10671681. DOI: 10.3390/ijms242216419.
Gressler A, Leng H, Zinecker H, Simon A Semin Immunol. 2023; 70:101838.
PMID: 37708826 PMC: 10804938. DOI: 10.1016/j.smim.2023.101838.
Longevity, Centenarians and Modified Cellular Proteodynamics.
Frankowska N, Bryl E, Fulop T, Witkowski J Int J Mol Sci. 2023; 24(3).
PMID: 36769212 PMC: 9918038. DOI: 10.3390/ijms24032888.
Proteolysis dysfunction in the process of aging and age-related diseases.
Frankowska N, Lisowska K, Witkowski J Front Aging. 2022; 3:927630.
PMID: 35958270 PMC: 9361021. DOI: 10.3389/fragi.2022.927630.
Immunosenescence and COVID-19.
Witkowski J, Fulop T, Bryl E Mech Ageing Dev. 2022; 204:111672.
PMID: 35378106 PMC: 8975602. DOI: 10.1016/j.mad.2022.111672.